Related Experiment Video

Updated: Jun 3, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

Abrocitinib-induced acute generalized exanthematous pustulosis

Yi Lu1, Qing Sun1

  • 1Department of Dermatology, Qilu Hospital of Shandong University, Jinan, China.

The Journal of Dermatology
|January 11, 2025
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

992
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

992
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.8K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K

Articles linked to this work by shared authors, journal, and citation graph.

Polyphenol-Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery.

Advanced materials (Deerfield Beach, Fla.)·2021

Controllable morphology of electrospun nanofiber membranes with tunable groove structure and the enhanced filtration performance for ultrafine particulates.

Nanotechnology·2021

A general approach to high-efficiency perovskite solar cells by any antisolvent.

Nature communications·2021

Cropping systems alter hydraulic traits of barley but not pea grown in mixture.

Plant, cell & environment·2021

Quercetin Attenuates Diabetic Peripheral Neuropathy by Correcting Mitochondrial Abnormality via Activation of AMPK/PGC-1α Pathway <i>in vivo</i> and <i>in vitro</i>.

Frontiers in neuroscience·2021

Neurovascular Units and Neural-Glia Networks in Intracerebral Hemorrhage: from Mechanisms to Translation.

Translational stroke research·2021

Oral Tetracycline Use in Children and Adolescents in Japan: Trends, Indications, and Treatment Patterns.

The Journal of dermatology·2026

IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients.

The Journal of dermatology·2026

Restraint-Free Initiation of Dupilumab in a Child With Autism Spectrum Disorder: Overcoming Procedural Barriers in Atopic Dermatitis.

The Journal of dermatology·2026

Topical β-Blocker as a Novel Treatment Option for Periungual Pyogenic Granuloma: A Retrospective Study of Lesion Size Reduction and Pain Improvement.

The Journal of dermatology·2026

Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.

The Journal of dermatology·2026

Hand Eczema Referred for Patch Testing: Retrospective Study in Shanghai, China From 2018 to 2023.

The Journal of dermatology·2026

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Frontiers in medicine·2026

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Frontiers in allergy·2026

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Frontiers in immunology·2026

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Frontiers in immunology·2026

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Frontiers in immunology·2026

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us